Relationships between amiodarone dosage, drug concentrations, and adverse side effects
Authors:
- James J. HegerJHJames J. Heger
- Eric N. PrystowskyEPEric N. Prystowsky
- Douglas P. ZipesDZDouglas P. Zipes
- 1 October 1983
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 106 (4) , 931-935
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Amiodarone Pulmonary ToxicityAnnals of Internal Medicine, 1982
- High-Performance Liquid Chromatographic Measurement of Amiodarone and Its Desethyl MetaboliteTherapeutic Drug Monitoring, 1982
- Amiodarone kinetics after oral dosesClinical Pharmacology & Therapeutics, 1982
- Pharmacokinetics of amiodarone after intravenous and oral administrationEuropean Journal of Clinical Pharmacology, 1981
- Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapyJournal of Chromatography A, 1980
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974
- Amiodarone-PigmentierungDermatology, 1972
- A Peculiar Cutaneous Pigmentation from CordaroneDermatology, 1972